The Ensuring Patient Access to Critical Breakthrough Products Act, will help bridge a gap between FDA and CMS and improve patient access to breakthrough medical technologies for serious illnesses, S. 2998, to expedite CMS decision-making for innovative medical technologies.Continue reading
Category Archives: Government Affairs Blog
AZBio Watch List- The Final Tally
The Arizona Legislature has adjourned Sine Die as of May 7th, 2016 5:45 A.M.
Here is the final tally for the 2016 Legislative SessionContinue reading
AZBio Watch List as of May 15th
The Arizona Legislature has adjourned Sine Die as of May 7th, 2016 5:45 A.M.
The General Effective date will be August 6th, 2016 unless otherwise stated in the bill text.Continue reading
Life Science Leaders Comment on Medicare Part B Drug Payment Proposed Rule
The Arizona Bioindustry Association (AZBio) together with 42 other state bioindustry associations submited comments to the Centers for Medicare & Medicaid Services’ (CMS’s) Center for Medicare and Medicaid Innovation (CMMI) Medicare Part B Drug Payment Proposed Rule, released March 8, 2016.Continue reading
AZBio Watch List for April 25 2016
Learn more about the bills AZBio is tracking at the Arizona Legislature
Continue reading
AZBio Bill List for April 18 2016
AZBio Members are encouraged to share thoughts on these bills and others with the Government Affairs Committee. Email AZBioContinue reading
AZBio Watch List for April 11 2016
AZBio Members are encouraged to share thoughts on these bills and others with the Government Affairs Committee. Email AZBioContinue reading
Washington Update for March 2016
Each month, BIO provides the latest updates, issues and poll data on issues affecting our bioscience industry at the national level. Here’s what happened in February 2016.Continue reading